Back to Search
Start Over
Early 3-day course of remdesivir to prevent progression to severe Covid-19 in high-risk patients with hospital-acquired SARS-CoV-2 infection: preliminary results from two Italian outbreaks
- Publication Year :
- 2022
- Subjects :
- COVID-19
early treatment
nosocomial infection
Remdesivir
SARS-CoV-2
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......3659..a8191bbbac7e366c35da7433596d817a